The European Commission recently launched a targeted stakeholder consultation on draft Guidelines on Good Manufacturing Practice for Advanced Therapy Medicinal Products, pursuant to Article 5 of Regulation 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products and amending Directive 2001/83/EC, that requires the Commission to draw up guidelines on good manufacturing practice specific to advanced therapy medicinal products. EIPG has reviewed the documents and. following feedback from its members, has submitted its comments to the Commission.
-
-
News from EIPG
- EMA, new features for the PRIority Medicines (PRIME) scheme
- The proposals of the EU Commission for the revision of the IP legislation
- Webinar: Pharmacovigilance as a specialization and the role of the Pharmacovigilance Risk Assessment Committee (PRAC)
- The EU Commission proposal of the new pharmaceutical legislation
- Pioneer plan, UK’s alternative to support research and innovation
- Trends for the future of the pharmaceutical manufacturing
- PIC/S new guidance documents for GDP inspectors